News Autoimmune Diseases Like MS Can Be “Switched Off,” According To Bristol Scientists Autoimmune Diseases Like MS Can Be “Switched Off,” According To Bristol Scientists by Patricia Silva, PhD | September 4, 2014 Share this article: Share article via email Copy article link Researchers from the University of Bristol have found a way of convert the function of cells into protecting the body instead of destroying healthy tissue, in what could be an important breakthrough for the treatment of debilitating autoimmune diseases in which the immune system mistakenly attacks the body, like multiple sclerosis (MS). This kind of conversion has already been applied to other diseases, but this is the first time that scientists are trying to take a similar approach with autoimmune-type diseases. The research team, which was led by professor David Wraith and includedĀ academics in Bristol UniversityāsĀ School of Cellular and Molecular MedicineĀ andĀ Department of Computer Science, was able to selectively target the cells responsible for the autoimmune disease, attenuating the attack against the body’s healthy tissue, as well as convert them into cellsĀ capable of protecting against disease. āInsight into the molecular basis of antigen-specific immunotherapy opens up exciting new opportunities to enhance the selectivity of the approach while providing valuable markers with which to measure effective treatment,” Dr. David Wraith in a press release. “These findings have important implications for the many patients suffering from autoimmune conditions that are currently difficult to treat.ā The study revealed that administrating fragments of the proteins, which usually attack the body, can redirect the autoimmune response. As a result, effective treatment for a disease such as Multiple Sclerosis is possible byĀ increasing the dose of antigenic fragment administrated to patients. During their research, the scientists examined the function of the immune cells themselves in order to understand how theĀ immunotherapy works, andĀ which genes and proteins were turned on or off by the treatment. The changes in gene expression that the researchers found suggest that effective treatment is able to convert the aggressive behavior of cells into a protector role, resulting inĀ reinstating self-tolerance, which means that the immune system restarts to ignore its healthy tissues, instead protecting against infection. If proven effective, the treatment may be able to alter the life of theĀ 2.5 million people worldwide who suffer from MS, since it can prevent patients from needing to takeĀ immune suppressive drugs associated with side effects like infections, development of tumors, and disruption of natural regulatory mechanisms, byĀ specifically targeting the cells at fault. [adrotate group=”4″] The conversion performed by the scientists is a process that was already used in treating allergies, known as “allergic desensitization,” however, its application to autoimmune diseases has never been performed before.Ā It is currently undergoing clinical developmentĀ through biotechnology companyĀ Apitope, a spin-off of the University of Bristol. The scientists believe that the findings can lead to theĀ use of antigen-specific immunotherapy as a treatment not only for MS, but also for other autoimmune disorders, such as type 1 diabetes, Gravesā disease, and systemic lupus erythematosus (SLE).Ā The study, which was funded by theĀ Wellcome Trust, was recently published at theĀ Nature CommunicationsĀ journal, entitled, “Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy.” .” Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags autoimmune disease, immune system
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Long-term data support early Kesimpta start in relapsing MS
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8